Skip to main content

Table 1 Expression patterns of TMED3 in malignant melanoma tissues and para-carcinoma tissues revealed in immunohistochemistry analysis

From: TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway

TMED3 expression

Tumor tissue

Para-carcinoma tissue

P value

Cases

Percentage

Cases

Percentage

Low

80

47.9%

29

96.7%

P < 0.001

High

87

52.1%

1

3.3%